微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.22% | -17.42% | 41.14% | 69/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.99% | -18.08% | 54.12% | 62/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.94% | -21.46% | -65.42% | 60/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.61% | -36.82% | 9.78% | 56/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.11% | -31.59% | 40% | 69/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.65% | -16.28% | 47.77% | 57/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.47% | -17.11% | -72.18% | 49/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 8.88% | -4.72% | 18.88% | 51/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.47% | -5.08% | 71.33% | 51/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.36% | -11.02% | 46.31% | 55/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.98% | 15.5% | -68.03% | 37/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 9.32% | 2.87% | 18.42% | 45/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.87% | -4.95% | 60.61% | 54/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.9% | -11.23% | 89.92% | 57/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.58% | 13.16% | -71.52% | 53/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.06% | 27.79% | 9.42% | 61/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.28% | 34.2% | 50% | 46/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.52% | 51.23% | 142.11% | 47/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.28% | 235.29% | -67.84% | 47/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 7.09% | 267.36% | 14.91% | 76/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.17% | 43.82% | 69.04% | 58/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.65% | 129.56% | 436.76% | 65/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.68% | -28.42% | -64.77% | 90/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.93% | -82% | -55.01% | 110/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.29% | -49.23% | 169.81% | 75/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.59% | -77.29% | 67.37% | 89/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.95% | -67.24% | -91.14% | 79/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 10.72% | -41.32% | 26.86% | 45/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.45% | 2% | 20.71% | 40/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7% | -30.56% | 141.38% | 28/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.9% | 2% | -84.13% | 28/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 18.27% | -38.34% | 81.25% | 28/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 10.08% | -42.79% | -65.98% | 14/158 | 3.86% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 29.63% | 2% | 68.16% | 9/158 | 11.35% | 德展健康 | 29.5% | 行业排名> |
| 2015-06-30 | 17.62% | 2% | 2% | 3/158 | 4.9% | 贝达药业 | 16.78% | 行业排名> |